LINAGLIPTIN AND METFORMIN HYDROCHLORIDE

1266 reported adverse events

Drug classes: Dipeptidyl Peptidase 4 Inhibitor [EPC]

These side effects are most commonly reported by patients taking LINAGLIPTIN AND METFORMIN HYDROCHLORIDE:

# Side effect Count
0 BLOOD GLUCOSE INCREASED 100
1 DIARRHOEA 95
2 NAUSEA 68
3 VOMITING 60
4 DRUG INEFFECTIVE 55
5 OFF LABEL USE 47
6 FATIGUE 46
7 DIZZINESS 44
8 PAIN 44
9 HEADACHE 42
See all common reactions for LINAGLIPTIN AND METFORMIN HYDROCHLORIDE

LINAGLIPTIN AND METFORMIN HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HAEMATOCRIT INCREASED 7 0.0031
1 IMMUNE-MEDIATED MYOSITIS 8 0.0029
2 HAEMOGLOBIN INCREASED 7 0.0015
3 KETOACIDOSIS 11 0.0015
4 HYPOVOLAEMIA 7 0.0012
5 BLOOD GLUCOSE ABNORMAL 19 0.0010
6 VITAMIN D DECREASED 8 0.0009
7 GLYCOSYLATED HAEMOGLOBIN INCREASED 23 0.0009
8 LACTIC ACIDOSIS 26 0.0008
9 HYPERCHOLESTEROLAEMIA 7 0.0007
See all enriched reactions for LINAGLIPTIN AND METFORMIN HYDROCHLORIDE